MaxCyte's market cap is currently ―. The company's EPS TTM is p-0.28; its P/E ratio is -14.51; MaxCyte is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is p-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 15.66M	$ 8.00M	$ 9.04M	$ 8.58M	$ 12.42M
Gross Profit	$ 14.09M	$ 7.21M	$ 7.67M	$ 7.58M	$ 10.88M
EBIT	$ 3.47M	$ -11.25M	$ -10.51M	$ -10.88M	$ -6.76M
EBITDA	$ 12.23M	$ -11.65M	$ -11.40M	$ -11.65M	$ -5.89M
Net Income Common Stockholders	$ -5.28M	$ -11.25M	$ -10.51M	$ -10.88M	$ -4.81M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 168.29M	$ 190.24M	$ 216.11M	$ 224.65M	$ 227.34M
Total Assets	$ 268.27M	$ 266.73M	$ 271.20M	$ 281.54M	$ 286.65M
Total Debt	$ 18.74M	$ 16.08M	$ 16.21M	$ 16.25M	$ 16.09M
Net Debt	$ -149.54M	$ -174.16M	$ -199.90M	$ -208.40M	$ -211.24M
Total Liabilities	$ 36.11M	$ 33.35M	$ 30.22M	$ 33.73M	$ 32.69M
Stockholders Equity	$ 232.17M	$ 233.38M	$ 240.98M	$ 247.82M	$ 253.97M
Cash Flow	-
Free Cash Flow	$ 66.80K	$ -8.96M	$ -10.61M	$ -5.87M	$ -8.28M
Operating Cash Flow	$ 981.70K	$ -8.24M	$ -10.10M	$ -4.32M	$ -6.09M
Investing Cash Flow	$ -4.14M	$ 2.81M	$ 26.67M	$ 29.64M	$ -27.10M
Financing Cash Flow	$ 493.00K	$ 36.70K	$ 156.70K	$ 1.46M	$ 1.23M

Currency in USD

MaxCyte Earnings and Revenue History

Income Statement >

MaxCyte Debt to Assets

Balance Sheet >

MaxCyte Cash Flow

Cash Flow >

MaxCyte Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing